×
戻る Agenda
S28 : Paradigm Shift in Oncology Drug Development ~ Challenging Dose Optimization with Clinical Pharmacology Approach ~
Session Chair(s)
Naoki Kotani, PHD
Pharmaceutical Science Dept. , Chugai Pharmaceutical Co., Ltd., Japan
Speaker(s)
Saki Takahashi
Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd., Japan
Emi Kamiyama
Associate Director, Quantitative Clinical Pharmacology Department, Daiichi Sankyo Company, Limited, Japan
Takafumi Koyama
Head of Physicians, Department of Experimental Therapeutics, National Cancer Center Hospital, Japan
Dose Optimization from the Viewpoint of Phase 1 Trialist
Takahiro Ito
, Pharmaceuticals and Medical Devices Agency (PMDA), Japan